SCHEMBL535585

SCHEMBL535585

CCC(N)(O)C(=O)OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
TDP1 Q9NUW8 3/20 0.47
KMT2A Q03164 2/20 0.47
MAPK1 P28482 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
MEN1 O00255 1/20 0.47
PTPN1 P18031 2/20 0.45
PTPRC P08575 1/20 0.45
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HTR2C P28335 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4623371 0.85 ALDH1A1 (0.55) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL21239496 0.85 ALDH1A1 (0.55) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL6108042 0.84 ALDH1A1 (0.58) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL28878544 0.83 ALDH1A1 (0.53) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL29291809 0.83 ALDH1A1 (0.53) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL7206146 0.83 ALDH1A1 (0.53) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL7944901 0.83 ALDH1A1 (0.56) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL8580399 0.83 ALDH1A1 (0.56) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL8643594 0.82 ALDH1A1 (0.51) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL4550673 0.82 ALDH1A1 (0.51) ALDH1A1TDP1KMT2AMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119101668-B Mutant enzyme, fermentation production method thereof and application of mutant enzyme in preparation of buckwheat alkali 华南师范大学 2025-05-09 CN claimed
CN-119101668-A Mutant enzyme, fermentation production method thereof and application of mutant enzyme in preparation of buckwheat alkali 华南师范大学 2024-12-10 CN claimed
CN-119101668-B Mutant enzyme, fermentation production method thereof and application of mutant enzyme in preparation of buckwheat alkali 华南师范大学 2025-05-09 CN disclosed
CN-119101668-A Mutant enzyme, fermentation production method thereof and application of mutant enzyme in preparation of buckwheat alkali 华南师范大学 2024-12-10 CN disclosed
US-10174132-B2 Heparan sulfate synthesis UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2019-01-08 US disclosed
US-20160060365-A1 HEPARAN SULFATE SYNTHESIS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2016-03-03 US disclosed
US-20120142560-A1 HEPARAN SULFATE SYNTHESIS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-06-07 US disclosed
EP-2414371-A2 HEPARAN SULFATE SYNTHESIS The University Of Georgia Research Foundation, Inc (US) 2012-02-08 EP disclosed
WO-2010117803-A2 HEPARAN SULFATE SYNTHESIS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2010-10-14 WO disclosed
US-20100256098-A1 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2010-10-07 US disclosed
EP-2188296-A1 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS The United States Of America, As Represented By The Secretary, Department Of Health And Human Services (US) 2010-05-26 EP disclosed
WO-2009029844-A1 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-03-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256098-A1 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS WAPL, WDR1, DUSP1 ALDH1A1 1064/4885TDP1 1049/4885KMT2A 1591/4885
US-10174132-B2 Heparan sulfate synthesis HPSE, STT3B, DDOST ALDH1A1 3615/4885TDP1 4697/4885KMT2A 2909/4885
US-20160060365-A1 HEPARAN SULFATE SYNTHESIS HPSE, STT3B, DDOST ALDH1A1 3615/4885TDP1 4697/4885KMT2A 2909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.